| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | $652.4M-17.3% | $788.4M+114.0% | $368.4M | — | — | — |
| Restricted cash | $404.6M+115.4% | $187.8M+89.0% | $99.4M-9.7% | $110.1M-46.2% | $204.6M+238.2% | $60.5M |
| Loans (at fair value) | $984.6M+22.1% | $806.3M-30.3% | $1.16B+14.4% | $1.01B+300.2% | $252.5M+221.8% | $78.5M |
| Property, equipment, and software, net | $44.2M+13.2% | $39.0M-8.5% | $42.7M-3.4% | $44.2M+82.1% | $24.3M+141.8% | $10.0M |
| Operating lease right of use assets | $16.4M-62.2% | $43.5M-20.5% | $54.7M-36.6% | $86.3M-10.2% | $96.1M+424.9% | $18.3M |
| Beneficial interest assets (at fair value) | $396.2M+124.0% | $176.8M+331.2% | $41.0M | $0 | — | — |
| Line of credit receivable (at fair value) | $112.7M+100.4% | $56.3M | — | — | — | — |
| Non-marketable equity securities | $41.3M+0.0% | $41.3M+0.0% | $41.3M+0.0% | $41.3M+3.1% | $40.0M | $0 |
| Goodwill | $67.1M+0.0% | $67.1M+0.0% | $67.1M+0.0% | $67.1M+0.0% | $67.1M | $0 |
| Other assets (includes $51,358 and $138,582 at fair value as of December 31, 2024 and December 31, 2025, respectively) | $255.4M+59.1% | $160.5M+9.8% | $146.2M-5.3% | $154.4M+19.3% | $129.4M+223.1% | $40.0M |
| Total assets | $2.97B+25.7% | $2.37B+17.3% | $2.02B+4.2% | $1.94B+6.4% | $1.82B+281.4% | $477.3M |
| Payable to investors | $107.7M+78.9% | $60.2M+12.3% | $53.6M-41.0% | $90.8M-15.6% | $107.6M+136.5% | $45.5M |
| Borrowings | $1.83B+30.5% | $1.40B+34.8% | $1.04B+5.5% | $986.4M+41.8% | $695.4M+1010.5% | $62.6M |
| Payable to securitization note holders (at fair value) | $46.5M-46.7% | $87.3M-38.3% | $141.4M | $0 | — | — |
| Accrued expenses and other liabilities (includes $15,883 and $15,219 at fair value as of December 31, 2024 and December 31, 2025, respectively) | $171.5M+28.2% | $133.8M+59.2% | $84.1M+25.6% | $66.9M-35.3% | $103.4M+189.9% | $35.7M |
| Operating lease liabilities | $21.1M-57.9% | $50.3M-19.3% | $62.3M-38.2% | $100.8M+0.4% | $100.4M+416.5% | $19.4M |
| Total liabilities | $2.18B+25.5% | $1.73B+25.5% | $1.38B+9.4% | $1.26B+24.7% | $1.01B+472.5% | $177.0M |
| Common stock, $0.0001 par value; 700,000,000 shares authorized; 93,469,721 and 98,033,361 shares issued and outstanding as of December 31, 2024 and December 31, 2025, respectively | $10K+11.1% | $9K+0.0% | $9K+12.5% | $8K+0.0% | $8K+14.3% | $7K |
| Additional paid-in capital | $1.16B+10.7% | $1.04B+13.8% | $917.9M+28.4% | $714.9M-3.5% | $740.8M+100.5% | $369.5M |
| Accumulated deficit | -$357.6M+13.0% | -$411.2M-45.5% | -$282.6M-565.8% | -$42.4M-164.1% | $66.2M+195.7% | -$69.2M |
| Total stockholders’ equity | $798.8M+26.2% | $633.2M-0.3% | $635.3M-5.5% | $672.4M-16.7% | $807.1M+168.8% | $300.3M |
| Total liabilities and stockholders’ equity | $2.97B+25.7% | $2.37B+17.3% | $2.02B+4.2% | $1.94B+6.4% | $1.82B+281.4% | $477.3M |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.